Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Brown-Frandsen, Kirstine
39  Ergebnisse:
Personensuche X
?
1

Long-term kidney outcomes of semaglutide in obesity and car..:

Colhoun, Helen M. ; Lingvay, Ildiko ; Brown, Paul M....
Nature Medicine.  30 (2024)  7 - p. 2058-2066 , 2024
Link: https://doi.org/10.1038/..
 
?
2

#2496 Effect of semaglutide on kidney outcomes in people wi..:

Colhoun, Helen M ; Lingvay, Ildiko ; Brown, Paul M...
Nephrology Dialysis Transplantation.  39 (2024)  Supplement_1 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
3

Semaglutide Effects on Cardiovascular Outcomes in People Wi..:

Ryan, Donna H. ; Lingvay, Ildiko ; Colhoun, Helen M....
American Heart Journal.  229 (2020)  - p. 61-69 , 2020
Link: https://doi.org/10.1016/..
 
?
4

Rates of Major Adverse Cardiovascular Events and Mortality ..:

Brown-Frandsen, Kirstine ; Emerson, Scott S. ; Marso, Steven P....
Canadian Journal of Diabetes.  42 (2018)  5 - p. S7-S8 , 2018
Link: https://doi.org/10.1016/..
 
?
5

Étude LEADER : liraglutide et évolution de la fonction réna..:

Marre, Michel ; Bouzidi, Amira ; Mann, Johannes F.E....
Diabetes & Metabolism.  43 (2017)  2 - p. A35 , 2017
Link: https://doi.org/10.1016/..
 
?
6

Day-to-day fasting glycaemic variability in DEVOTE: associa..:

on behalf of the DEVOTE Study Group ; Zinman, Bernard ; Marso, Steven P....
Diabetologia.  61 (2017)  1 - p. 48-57 , 2017
Link: https://doi.org/10.1007/..
 
?
7

DEVOTE 3: temporal relationships between severe hypoglycaem..:

on behalf of the DEVOTE Study Group ; Pieber, Thomas R. ; Marso, Steven P....
Diabetologia.  61 (2017)  1 - p. 58-65 , 2017
Link: https://doi.org/10.1007/..
 
?
8

Effects of oral semaglutide on cardiovascular outcomes in i..:

McGuire, Darren K ; Busui, Rodica P ; Ripa, Maria Sejersten...
info:eu-repo/semantics/altIdentifier/doi/10.18154/RWTH-CONV-251529.  , 2023
Link: https://publications.rwt..
 
?
9

Liraglutide and renal outcomes in type 2 diabetes:

Mann, Johannes F. E ; Ørsted, David D ; Brown-Frandsen, Kirstine...
info:eu-repo/semantics/altIdentifier/pmid/28854085.  , 2017
Link: http://hdl.handle.net/11..
 
?
10

Liraglutide and Renal Outcomes in Type 2 Diabetes:

Mann, Johannes F E ; Ørsted, David D ; Brown-Frandsen, Kirstine...
info:eu-repo/semantics/altIdentifier/pmid/28854085.  , 2017
Link: https://hdl.handle.net/1..
 
?
11

Efficacy and safety of degludec versus Glargine in Type 2 D..:

Marso, Steven P ; Mcguire, Darren K ; Zinman, Bernard...
info:eu-repo/semantics/altIdentifier/pmid/28605603.  , 2017
Link: http://hdl.handle.net/11..
 
?
12

Efficacy and Safety of Degludec versus Glargine in Type 2 D..:

Marso, Steven P ; McGuire, Darren K ; Zinman, Bernard...
info:eu-repo/semantics/altIdentifier/pmid/28605603.  , 2017
Link: https://hdl.handle.net/1..
 
?
13

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes:

Marso, Steven P ; Daniels, Gilbert H ; Brown-Frandsen, Kirstine...
https://portal.findresearcher.sdu.dk/da/publications/1778c0b8-f4c9-4c05-b382-53c64128d79d.  , 2016
Link: https://portal.findresea..
 
?
14

Design of DEVOTE (Trial Comparing Cardiovascular Safety of ..:

Marso, Steven P. ; McGuire, Darren K. ; Zinman, Bernard...
American Heart Journal.  179 (2016)  - p. 175-183 , 2016
Link: https://doi.org/10.1016/..
 
?
15

Design of the liraglutide effect and action in diabetes: Ev..:

Marso, Steven P. ; Poulter, Neil R. ; Nissen, Steven E....
American Heart Journal.  166 (2013)  5 - p. 823-830.e5 , 2013
Link: https://doi.org/10.1016/..
 
1-15